Next Article in Journal
Ferulic Acid as a Protective Antioxidant of Human Intestinal Epithelial Cells
Next Article in Special Issue
Oxo-Carotenoids as Efficient Superoxide Radical Scavengers
Previous Article in Journal
Redox Status of Postmenopausal Women with Single or Multiple Cardiometabolic Diseases Has a Similar Response to Mat Pilates Training
Previous Article in Special Issue
Total Phenolic Content, Biomass Composition, and Antioxidant Activity of Selected Marine Microalgal Species with Potential as Aquaculture Feed
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Scutellaria petiolata Hemsl. ex Lace & Prain (Lamiaceae).: A New Insight in Biomedical Therapies

1
Department of Botany, Hazara University Mansehra, Mansehra 21310, Pakistan
2
Natural and Medical Sciences Research Center, University of Nizwa, Birkat Al Mauz, Nizwa 616, Oman
3
Department of Botany, Abdul Wali Khan University Mardan, Mardan 23200, Pakistan
*
Authors to whom correspondence should be addressed.
Antioxidants 2022, 11(8), 1446; https://doi.org/10.3390/antiox11081446
Submission received: 3 June 2022 / Revised: 25 June 2022 / Accepted: 7 July 2022 / Published: 26 July 2022

Abstract

:
The recent investigation was designed to explore Scutellaria petiolata Hemsl. ex Lace & Prain (Lamiaceae) whole plant in various extracts (methanol (SPM), dichloromethane (SPDCM), n-Hexane (SPNH), and aqueous (SPAQ) for a phytochemicals assessment, ESI-LC-MS chemical analysis, in vitro antimicrobials, and antioxidants and in vivo anti-inflammatory and analgesic potential. The qualitative detection shows that all the representative groups were present in the analyzed samples. The examined samples display the greatest amount of total flavonoid content (TFC, 78.2 ± 0.22 mg QE/mg) and total phenolic contents (TPC, 66.2 ± 0.33 mg GAE/g) in the SPM extract. The SPM extract proceeded to the ESI-LC-MS to identify the chemical constituents that presented nineteen bioactive ingredients, depicted for the first time from S. petiolata mainly contributed by flavonoids. The analyzed samples produced considerable capability to defy the microbes. The SPM extract was observed effective and offered an appreciable zone of inhibition (ZOI), 17.8 ± 0.04 mm against the bacterial strain Salmonellatyphi and 18.8 ± 0.04 mm against Klebsiella pneumonia. Moreover, the SPM extract also exhibited 19.4 ± 0.01 mm against the bacterial strains Bacillus atrophaeus and 18.8 ± 0.04 mm against Bacillus subtilis in comparison to the standard levofloxacin (Gram-negative) and erythromycin (Gram-positive) bacterial strains that displayed 23.6 ± 0.02 mm and 23.2 ± 0.05 mm ZOI, correspondingly. In addition to that, the SPD fraction was noticed efficiently against the fungal strains used with ZOI 19.07 ± 0.02 mm against Aspergillus parasiticus and 18.87 ± 0.04 mm against the Aspergillus niger as equated to the standard with 21.5 ± 0.02 mm ZOI. In the DPPH (2,2-diphenyl-1-picrylhydrazyl) analysis, the SPM extract had the maximum scavenging capacity with IC50 of 78.75 ± 0.19 µg/mL succeeded by the SPDCM fraction with an IC50 of 140.50 ± 0.20 µg/mL free radicals scavenging potential. Through the ABTS (2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) assay, the similar extract (SPM) presented an IC50 = 85.91 ± 0.24 µg/mL followed by the SPDCM fractions with IC50 = 182.50 ± 0.35 µg/mL, and n-Hexane fractions were reported to be the least active between the tested samples in comparison to ascorbic acid of IC50 = 67.14 ± 0.25 µg/mL for DPPH and IC50 of 69.96 ± 0.18 µg/mL for ABTS assay. In the in vivo activities, the SPM extract was the most effective with 55.14% inhibition as compared to diclofenac sodium with 70.58% inhibition against animals. The same SPM crude extract with 50.88% inhibition had the most analgesic efficacy as compared to aspirin having 62.19% inhibition. Hence, it was assumed from our results that all the tested samples, especially the SPM and SPDCM extracts, have significant capabilities for the investigated activities that could be due to the presence of the bioactive compounds. Further research is needed to isolate the responsible chemical constituents to produce innovative medications.

1. Introduction

Medicinal plants are used throughout the globe for their multiple health benefits from the emergence of human civilization to date [1]. The therapeutic herbs are capable of producing many bioactive compounds attributed with promising antimicrobial, free radical scavenging, anti-inflammatory, analgesic, and numerous other healing properties against a variety of diseases [2]. The therapeutic significance attributed to the medicinal herbs is due to the presence of flavonoids, phenols, alkaloids, and other bioactive chemical ingredients [3,4,5]. These natural products help the human body in performing normal physiological functions [6]. The flavonoids and phenols serve as a potent source to scavenge the free radicals, resist microbes, cure inflammation and allay pain [7]. Alkaloids are known to perform metabolic roles. Hence, they mainly function in animal physiology [8]. Besides this, they also function as steroidal drugs, which are known as steroidal alkaloids [9]. The genus Scutellaria is mainly represented by flavonoids and phenolic constituents [10], such as glucuronides comprises baicalin and wogonin-7-Oglucuronide or aglycones that are wogonin-7-Oglucuronide baicalein and wogonin. Phenolic constituents can scavenge the free radicals, resist the pathogenic microbes and inhibit the platelet aggregation [11,12]. Saponin works as an expectorant, emulsifying and antifungal agent [13,14]. The leading role of steroids is to stimulate sex hormones [15]. Only one-third of infectious diseases are treated with the help of synthetic products [16]. In comparison to chemical drugs, natural drugs are reported to produce excellent and effective results having very less or no side effects. The emergence of multidrug-resistant microbes has limited the availability and affordability of numerous recommended marketed antibiotics over the globe [17]. Therefore, it diminishes the effectiveness of the medication procedures and increases the rate of morbidity, mortality, and enhances human health care expenses [18]. To overcome, the antimicrobial complications the researchers continue their efforts to search for new sources from the plants which is eventually a significant basis for the production of modern medication to overwhelm the socioeconomic and human health effects instigated by the microbes and other oxidative stress [19]. Multiple investigations emphasize that several natural plant-based antioxidant agents have been useful in addressing health complications associated with oxidative stress [20]. Some plants basis antioxidant sources have demonstrated promising biological impacts; having the capability to resist the human pathogenic microbes, relieve pain, and heal inflammation [21].The development of an effective anti-inflammatory medication product with a higher margin of safety has always been a challenge [22]. The pathogenic complications also lead to inflammation which is a recent and most terrifying challenge for the scientist to explore innovative products to overcome inflammations [23] for the reason that the intake of synthetic medications for the long term may produce adverse effects [24]. Thus, it is the basic need to search for an effective natural remedy that has the potential to cure inflammation and relieve pain with less side effects [25]. Despite recent advancements in pain medicines, scientists continue to seek out safe, effective, and strong analgesic medications derived from plants since they are known to produce low side effects [26,27]. The genus Scutellaria L. (Lamiaceae), also known as skullcap, consist of around three hundred and fifty plant species and is practiced as a traditional remedy in several local communities. The genus Scutellaria is cosmopolitan by habitat and is mainly found on the tail of mountains in the mildly hot and humid areas of East Asia, America, and Europe [28]. In Pakistan the Scutellaria species are mostly distributed in Swat, Chitral, Mansehra, and Parachinar [2,29,30,31]. The plant species of the genus Scutellaria used as traditional remedies and also depicted promising capabilities to resist microbes, purify the blood, regulate the menstrual cycle, and alleviate inflammation and relieve pain [32]. The mentioned feature of the genus is attributed due to the presence of a diverse range of responsible chemical ingredients: scutellarin, alkaloids, baicalin, tannins, saponins, and glycosides, which are well known for multiple health benefits, including antimicrobial and antioxidant, as well as for their substantial capabilities for the treatment of inflammation and pain [2]. The antimicrobial resistance of the Scutellaria species has been of great importance among investigators. The search for combinations of new anti-inflammatory and analgesics among vast sources of medicinal plants is intensifying. The main reason is that this type of data ensures the discovery of therapeutic medicines that can be recently produced and have the ability to scavenge the free radicals, cure inflammation and suppress, reduce, or alleviate pain [33,34]. Scutellaria petiolata (Lamiaceae) is a perennial chasmophytic, suffruticose herb with a hard woody rootstock and slender, erect, round–quadrangular simple or much-branched, eglandular leafy stem. The leaves are petiolate, along with thick-textured inferior and cauline ovate or generally ovate, entire, crenate or serrate, usually cuneate or particularly cordate acute to obtuse; the upper bract as an elliptic is full. Inflorescence is lax or more reduced, apical or lateral. Scattered flowers are in the axil of the bract, similar to leaves. The calyx is five, lacks the scutellum with expanding fruit, and the corolla are also five in number, having violet-blue color, with upright, pilose, and sessile glands. The nutlets are finely tuberculate together with a small fruit tuft of mostly long propagating multicellular eglandular hairs, mostly black. The flowering duration range from mid-May to September [35]. Scutellaria petiolata mainly distributed in colder regions on mountain tails of India, Afghanistan, Kashmir, and Pakistan. In Pakistan, S. petiolata is frequently found on the mountain tails of District Swat and Chitral [35].
The dried powder of the selected plant (root, stem, leaves, and flowers) is used by the local communities to overcome antimicrobial disorders, cure inflammation, and a remedy to relieve pain but still needs precise scientific corroboration.
Hence, the current investigation is carried out for the first time to seek out information regarding the efficiency of the selected plants for various health problems and reintroduce the importance of natural products in various health complications: in general, to capture the attention of scientists by screening them for their phytochemical composition, in vitro, antimicrobial, antioxidant capabilities, and in vivo pharmacological; anti-inflammatory and analgesic significance for S. petiolata for which they have never been examined earlier; and update the literature of genus Scutellaria.

2. Materials and Methods

2.1. Apparatus and Reagents Used

Methanol, dichloromethane, n-Hexane, and dimethyl sulfoxide (Fisher Scientific, Loughborough, UK), distilled water (Milli-Q, 31PB, France), rotavapor (BUCHI, 2017, Switzerland). ESI-LC-MS/MS (LTQ XL, Thermo Electron Corporation, Waltham, MA, USA) and Xcalibur 2.2 software (Thermo Fisher Scientific, Waltham, MA, USA) were purchased from Fisher Scientific (Illkirch, France). The solvents used for liquid chromatography were ESI-LC-MS grade acetonitrile (Fisher Scientific).

2.2. Collection and Identification of Plant Samples

The selected plant Scutellaria petiolata specimens were gathered (May–July 2018) from various spots of Kalam, District Swat, Khyber Pakhtunkhwa, Pakistan. The specimens were identified by the taxonomist Dr. Jan Alam Associate Professor, Department of Botany, Hazara University KP, Pakistan using available literature [35]. The plant specimen was properly preserved and placed in the herbarium Department of Botany (Herb⁄ HU⁄6642) Hazara University Mansehra Pakistan for future studies.

2.3. Plant Samples Processing

The Scutellaria petiolata specimens were cleaned with tap water to eradicate the useless materials and then placed under shade for complete dryness at room temperature to avoid the loss of essential and volatile ingredients.

2.3.1. Crude Extract Preparation

The dried plant samples were shredded with an electric grinder and gained 3700 g of fine powder. The powder was kept in covered bags in the refrigerator, at the temperature of 4 °C until needed. A lot (2700 g) of plant powder were soaked with 6 L, commercial-grade methanol (MeOH) in glass containers for crude extract preparation. The glass container was consistently agitated for 21 days and then the mixture (solubilize plant material and MeOH) was poured into a conical flask through Whatman filter paper. The remaining material on the filter paper was once again submerged in a mixture of 10%, water, and MeOH for an additional 21 days and repeated a similar process to get hold of the filtrate. The filtrates taken from both processes were mixed and evaporated at a temperature of 40 °C and 120 rpm via a rotary evaporator for the evaporation of the solvent MeOH. Eventually, crude extract in the form of semi-solid paste was obtained containing solvent which was further administrated in the hot water bath at 40 °C to remove the entire MeOH solvent. The same procedure was adopted for filtrates obtained again, and in the end, the crude extract (SPM) of 640 g proceeded further for fractionation.

2.3.2. Fractionation of Crude Extract

The crude extract of 600 g was homogenized with 1 L of distilled water and then shaken with the same quantity (1L) of n-Hexane (SPNH) and dichloromethane (SPDCM) using a separating funnel through solvent-solvent extraction. The formation of the clear band was observed among the solvents formed and each part was collected separately and passed through a rota evaporator using the same temperature of 40 °C and 120 rpm to obtain the targeted fractions. Eventually, the SPNH and SPDCM dry mass fractions at a quantity of 23 g and 31 g were obtained respectively. The SPAQ was noticed and yielded in a maximum quantity of 39 g as compared to the fractions.

2.4. Stock Solution

The crude extract (SPM) and each fraction (SPNH, SPDCM, and SPAQ) of S. petiolata at a mass of 2 g were homogenized in 10 mL DMSO (99.99%) to arrange a stock solution for the various phytochemicals and biological activities and placed in refrigerator till further use.

2.5. Qualitative Assessment of Phytochemical Detection

The S. petiolata extracts SPM, SPDCM, SPNH, and SPAQ were proceeded for the detection of various phytochemical analyses to validate the presence of representative groups of flavonoids, alkaloids, phenols, and carbohydrates applying the standard techniques [2,36,37].

2.5.1. Flavonoids

The presence of the flavonoids group was detected by adding a few drops in SPM, SPDCM, SPNH, and SPAQ of S. petiolata with 5% of NaOH solution, and then, a few drops of the HCl were added. Consequently, the changes from yellow to colorless showed the presence of flavonoids.

2.5.2. Phenols

A few drops from the stock solution of extracts SPM, SPDCM, SPNH, and SPAQ were treated with FeCl3 solution in glass tubes and then shaken. The change of the mixture to bluish-green color indicates the presence of the phenols group.

2.5.3. Alkaloids

The presence of alkaloid groups in the extracts SPM, SPDCM, SPNH, and SPAQ was carried out by the addition of 0.5 mL from the stock solution with 2% of the H2SO4 solution. The mixture was then placed in a hot water bath and after 3 min few droplets of Dragendorff’s reagent were added, and the glass tubes were placed aside for coolness. The change of mixture into orange-red color precipitate indicates alkaloids group.

2.5.4. Carbohydrates

In SPM, SPDCM, SPNH, and SPAQ extracts of S. petiolata, the presence of the carbohydrate was determined by the addition of 3 mL of the tested samples stock solution along with 2 mL of research-grade Benedict’s reagent in glass tubes. Later, the obtained mixture was kept in a hot water bath for 3 min. Finally, the color change to reddish-brown precipitates indicates the presence of the carbohydrate in the S. petiolata extracts.

2.6. Analytical Determination of Flavonoids and Phenols

The S. petiolata SPM, SPDCM, SPNH, and SPAQ extracts were profiled for the analytical evaluation of the total flavonoids (TFC) and total phenolic contents (TPC) using available literature standard procedure [2,38].

2.6.1. Quantification of Total Flavonoids Contents

For the flavonoid quantification in the tested samples SPM, SPDCM, SPNH, and SPAQ extracts of S. petiolata was represented as mg QE/g, and equivalent to the dry mass of the samples. About 9 mL of the distilled water (DW) was added with 1 mL from the stock solution of tested samples extract stock, with further addition of 1 mL from the 5% of NaNO2 in a glass test tube and then placed to incubate for 6 min. Next, around 2 mL from the 10% of AlCl3 was mixed into each sample in test tubes and then placed undisturbed for 5 min. Lastly, about 2 mL from 1 M of NaOH was put into each of the tested samples in the test tubes. The absorbance was checked at 510 nm employing a UV-visible spectrophotometer.

2.6.2. Estimation of Total Phenolic Contents

The Folin–Ciocalteu reagent (FCR) assay was used to determine the TPC in various extracts (SPM, SPDCM, SPNH, and SPAQ) of S. petiolata. The TPC was calculated as mg GAE/g, of the dry mass of the tested samples. The tested samples of 5 mg were added with 5 mL distilled methanol and then mixed with 10 mL of DW and kept undisturbed for 5 min. Around, 1 mL from the tested sample was taken in a glass test tube with the addition of DW till the volume of the samples reached 10 mL. After that, 1 mL of FCR was added up to each sample and incubated for 6 min. Right after the incubation, 10 mL from the 7% of Na2CO3 solution was mixed. Eventually, the final volume of the reaction mixture (tested samples) reached 26 mL with the further addition of DW and placed to incubate for 90 min at room temperature. The sample absorbance was observed at 760 nm via a UV-visible spectrophotometer.

2.7. ESI-LC-MS/MS Analysis

The SPM extract of S. petiolata was investigated to highlight its chemical ingredients via ESI-LC-MS analysis through linear ion trap mass spectrometer connected with electrospray ionization (ESI) source applying both positive and negative ionization mode through standard method [10,39]. The tentative identification of the compounds was attained using direct injection mode utilizing ESI. The capillary voltage was fixed at 3.3 kV at 280 °C, however, the sample flow rate was kept at 10.5 µL/min. The mass range was adjusted as 50–2000 m/z. The collision-induced dissociation (CID) energy varied from 10 to 30, while during MS/MS the energy range was maintained at 10–45, based on the nature of the parent molecular ion. In the mobile phase, the MeOH and acetonitrile ratio was fixed at 80:20 (v/v). Furthermore, the MS parameters for each compound were properly regulated to authenticate the extremely satisfactory ionization and ion transfer conditions. However, the best possible signals of both the precursor and fragment ions were achieved by infusing the analytes and manually modifying the parameters. The parameters sources were the same for all the analytes.

2.8. Biological Activities

The studies plant in extracts SPM, SPDCM, SPNH, and SPAQ were screened for their significance against the microbes and examined their potential to act as an antioxidant agent.

2.8.1. In Vitro Activities

In vitro biological activities including antimicrobial and antioxidants were performed to report the significance of S. petiolata extracts. The antimicrobial activity was carried out by using the bacterial strains; S. typhi, K. pneumonia, B. atrophaeus, B. subtilis, and fungal strains; A. parasiticus and A. niger. The microbial strains were taken from the Microbiology Lab and were properly identified by Dr. Hazir Rahman (Microbiologist) Department of Microbiology, AWKUM, Mardan.

2.8.2. Antibacterial Evaluation

The antibacterial potential of the S. petiolata extracts (SPM, SPDCM, SPNH, and SPAQ) was examined by agar well diffusion assay using the reported literature with slight modifications [2,40]. 1 mg from the tested samples were homogenized in 1 mL of Dimethyl sulfoxide (DMSO) to get 1000 ppm solution from where 50 and 100 µL volume were used for further analysis. To proceed with the antibacterial assessment nutrient agar media was prepared by adding 28 g of the nutrient agar with 1 L of distilled water followed by vigorously shaking until the media completely dissolved. The NA media, wire loop, well borer, and glass Petri dishes were autoclaved at 121 ℃ for 15 min for sterilization. Right after sterilization, the nutrient agar media of around 20 mL agar was poured into each Petri plate in the laminar flow hood until it solidifies. The bacterial strains (S. typhi, K. pneumonia, B. atrophaeus, B. subtilis) were properly inoculated via a wire loop using a safety kit keeping the concentration of bacterial cell density of (1.5 × 108 CFU/mL). On the solidified NA media of each Petri plate, five wells of equal size of 3 mm were made using a cork borer at the same distances from each other. The tested samples SPM, SPDCM, SPNH, and SPAQ at dosages of 50 µg⁄ml and 100 µg⁄ml was poured into the well first and second respectively while the third and fourth well was filled with the standard (Levofloxacin & Erythromycin) of equal concentration 50 µg⁄ml and 100 µg⁄ml) for the Gram-positive and Gram-negative strains, correspondingly. The DMSO which was used as a negative control was poured into the fifth well on the agar media. All the glass Petri dishes were kept overnight in the incubator at a temperature of 37 °C. Finally, the Petri plates were taken out from the incubator, and the zone of inhibition (ZOI) around the well was measured in mm. The entire data were taken in triplicates, statistically analyzed, and represented as mean ± SEM.

2.8.3. Antifungal Assessment

The antifungal potential of the tested samples of S. petiolata was conducted using an agar well diffusion assay as described by Shah et al. [2]. Dosages from the SPM, SPDCM, SPNH, and SPAQ extracts at concentrations (50 µg/mL and 100 µg/mL), as earlier mentioned for antibacterial activity. Thirty-nine (39) grams of potato dextrose agar (PDA) was added with1 L of distilled water in a conical flask and covered followed by continuous shaking till it homogenized. All the required materials comprising PDA media, glass Petri plates, wire loop, and steel borer (3 mm) were carefully autoclaved at 121 °C for 20 min. After sterilization, the media of around 20 mL was poured into each Petri plate under aseptic and then kept undisturbed till to solidify the media. The fungal inoculant (A. parasiticus and A. niger) at a concentration of 108–109 CFU/mL was spread over the solidified PDA media and five holes of equal size (3mm) were made at the same distance from each other. The extract dosage of 50 µg/mL and 100 µg/mL was injected into wells 1 and 2, and the antifungal standard (Fluconazole) at the same concentration 50 µg/mL and 100 µg/mL was added to the third and fourth wells, and the fifth hole was filled with the negative control (DMSO), respectively. After that, the Petri dishes were properly packed and incubated for 72 h at 25 °C in the incubator. Finally, the Petri plates were taken out and ZOI was calculated around the hole in mm. All the antimicrobial data were taken in triplicates and represented as the mean ± SEM.

2.8.4. Antioxidant Determination

The free radicals scavenging significance in the tested fractions (SPM, SPDCM, SPNH, and SPAQ) were examined using the most reported 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2 -azino-bis (3-ethylbenzothiazoline-6-sulfonic acid (ABTS) bioassay [2,41,42]. The antioxidant capacity was performed through a DPPH assay by taking 3 mg of DPPH and homogenizing properly 100 mL distilled methanol and placing an undisturbed to form the free radicals in the solution in dark for 30 min. The concentrations (1000, 500, 250, 125 and 62.5 µg/mL) of the tested samples including standard ascorbic acid were properly prepared. Later, 2 mL from the SPM, SPDCM, SPNH, and SPAQ extracts, and ascorbic acid were added to the 2 mL stock solution of DPPH and then placed to incubate for 20 min in the dark. Right after the incubation, the absorbance of tested samples was observed at 517 nm using UV/Vis spectrophotometer. The scavenging capability in the tested samples was calculated using equation.
% Free radicals scavenging activity = A − B ⁄A × 100
whereas A represents absorbance of the control and B represents the absorbance of the standard.
ABTS assay was also used to analyze the free radical scavenging potential of the tested samples. To proceed with the ABTS assay, around 383 mg of ABTS and 66.2 mg of the K2S2O8 were separately homogenized in 100 mL of the MeOH, and then, both were mixed. After that, 2 mL of the mixture were placed to incubate with 2 mL of tested samples at a concentration of (1000, 500, 250, 125, and 62.5 µg/mL) for 25 min. Finally, the absorbance of the tested samples was measured at 746 nm via UV spectrophotometer, and the results were estimated using Equation (1).

2.9. In Vivo Activities

The selected plant was screened in various tested samples to examine their in vivo anti-inflammatory and analgesic significance.

2.9.1. Ethical Approval

Ethical approval for the experimental animals (Swiss albino mice) with body weight (B.w) around (25–30 g) was taken from the official ethical committee of Abdul Wali Khan University Mardan (AWKUM) with (Ref. No: AWKUM/Bot/2018/1679, Dated: 8 November 2018), Department of Botany, AWKUM (if needed will be provided). The experimental animals were purchased from the veterinary research institute Peshawar and kept under an aseptic condition in rubber cages for around 45 days at a maintained temperature of 20 °C at the animal house of AWKUM following ARRIVE guidelines as stated by Du et al. [43]

2.9.2. Anti-Inflammatory Activities

The selected plant in various extracts (SPM, SPDCM, SPNH, and SPAQ) was examined for anti-inflammatory activities using the standard method with slight modification [2]. To progress the anti-inflammatory activity, 30 mice in 5 groups were taken with 6 experimental animals in each group for the tested samples (plant fractions, negative control, and standard).
To induce paw edema, carrageenan 1 mL was injected into the paws of all six groups of the Swiss albino mice. Right after 30 min, around 1 mL of the normal saline (NS) was infused into the paw of the group second mice to estimate the anti-inflammatory efficacy, and then 1 mL of the standard diclofenac sodium (DS) was injected to the paw of third experimental animals’ group. Furthermore, the dosage at concentrations of 50 and 100 mg/kg/body weight (BW) was injected into the 4 and 5 groups of the experimental animals correspondingly. The paw diameter of the Swiss albino mice was calculated and observed after 1, 2, and 3 h, respectively, and represented% inhibition using Equation (2).
% Inhibition of the tested samples = a− b ⁄a × 100
where (a) inducer (carrageenan) and (b) inhibition of the tested sample (crude oils, standard, and control), whereas in analgesic activity (a) represents the writhes inducer acetic acid.

2.9.3. Analgesic Activities

The analgesic capacity of S. petiolata in extracts (SPM, SPDCM, SPNH, and SPAQ) was examined using acetic acid-induced writhing bioassay using experimental animals (Swiss albino mice) [2,41]. To proceed with the analgesic activity, 30 mice were taken and evenly arrange into five groups and each group contain 6 mice. The tested samples SPM, SPDCM, SPNH, and SPAQ along with the negative control, and standard were injected into the Swiss albino mice through intraperitoneal muscle via an authorized size sterilized syringe. Around 1 mL of acetic acid was infused into each group (1–5) of the Swiss albino mice. Right after 30 min, 1 mL of NS (negative control) and 1 mL of the standards (aspirin) were injected into the second and third groups of the experimental animals respectively. Furthermore, the fractions SPM, SPDCM, SPNH, and SPAQ at dosages 50 and 100 mg/kg B.W were injected into the experimental animals of groups 4 and 5 accordingly.
The writhes induced through the acetic acid were calculated and compared with the negative control and standard for 10 min. The results were obtained through Equation (2), authentic through statistical analysis, and expressed as% inhibition.

2.10. Statistical Analysis

The recorded data were analyzed through one-way analysis of variance (ANOVA), following Bonferroni’s and the significance level: p = 0.05 represented as (*) and 0.01 denoted with (**) using two-way ANOVA, while Tukey’s multiple comparison test, ns = >0.9999, p = **** <0.0001 was followed for antimicrobial activities. However, the antioxidants significance was determined through a nonlinear regression graph (NLRG) and was designed among the% inhibition and dosages of the tested samples, and the IC50 was estimated via GraphPad Prism 9 software for Windows (GraphPad-Software, San Diego, CA, USA, 2020) through the equation below:
Y = 100/1 + (ˆHill Slope)
where 1 denotes the inhibitors, Y for the inhibitor’s reaction, and Hill Slope demonstrates the steepness of the curves.

3. Results and Discussion

Medicinal plants are an affluents basis for the mass production of drugs. The medicinal plants are selected based on the information regarding ethnopharmacology collected from the local practitioners and communities [44]. Plant’s traditional uses are authenticated by screening the composition of the bioactive ingredients followed by their in vitro and in vivo studies, which are fundamental procedures for determining a plant’s therapeutic potential [45]. Medicinal plants contain responsible bioactive ingredients, such as flavonoids, phenols, and alkaloids. These chemical constituents have multiple health benefits [46]. Environmental variables have a significant impact on the quantity of phytochemical ingredients [47]. Light, soil fertility, soil water, temperature, and salinity, which are known as the external factors and variables, have a significant impact on some of the processes that are mostly that are linked with the development and growth of the plants. Moreover, the ability to produce different secondary metabolites thus causes alterations in the entire phytochemical profiles that are involved in bioactive substance generation [48]. To put it another way, plants can produce secondary metabolites gradually according to the stress created due to the environment. The secondary metabolism of plants can be thought of as a plant’s ability to adapt and survive in response to environmental stimuli throughout its life [49].

3.1. Phytochemicals Qualitative Detection

Phytochemical detection of the representative groups to highlight the significance of S. petiolata based on which they proceeded to various biological studies. Flavonoids, phenols, alkaloids, and carbohydrates were found in all tested samples except in the SPNH fraction in which flavonoids, alkaloids, and carbohydrates were not detected. Additionally, from the examinations, it has been found that the flavonoids were found in significant amounts in all extracts rather than the other bioactive compounds. From the results, the aqueous extract presents negligible or lower positive results, whereas a moderate amount of bioactive was present in the other fractions. The current findings support the literature stated by Shah et al. [2] for S. edelbergii. Flavonoids are the dominant group in the genus Scutellaria as reflected in the data noticed by Shang et al. [32]. The findings are inconsistent with the data published by Stepanova et al. [50] for phenols who identified the most active bioactive compounds in Scutellaria. The results showed that among all the identified bioactive compounds, flavonoids are largely present. The results are clarified with the help of data presented in Table 1.

3.2. Assessment of Total Flavonoids and Phenols

The understudy plant in extracts SPM, SPDCM, SPNH, and SPAQ was investigated for the quantitative estimation of total flavonoids and flavonoid contents.

Flavonoids and Phenols Contents

The determination of S. petiolata in various extracts revealed that a significant quantity of flavonoids was around 78.2 ± 0.22 ** mg QE/mg in the SPM extract, followed by the SPDCM and SPAQ extracts with a quantity of 67.4 ± 0.15 ** mg QE/mg, and 49.4 ± 0.37 ** mg QE/mg, respectively, while the least quantity of flavonoids was observed in the SPNH fraction extract, which was found to be about 46.2 ± 0.66 ** mg QE/mg. Similarly, the SPM extract also consists of significant levels of total phenols of 66.2 ± 0.33 ** mg GAE/g, followed by SPDCM and aqueous extract with the quantity of 61.5 ± 0.66 ** mg GAE/g, 41.3 ± 0.33 ** mg GAE/g for phenols, respectively, shown in Table 2. In addition to that, the minimum quantity of phenols was recorded in the SPNH fraction of S. petiolata. According to Table 2, the SPNH fraction displayed negligible levels in both flavonoids and phenols in comparison to the other extract. The current outcomes are correlated with that of the research conducted by the researchers Liu et al. [51] and Shah et al. [2] for Scutellaria platystegia and S. edelbergii respectively to determine their phenolic and flavonoid contents. The current findings depicted a little variation with the screening described by Park et al. [52] and Chen et al. [53] for S. baicalensis. The variation in the quantity of the total phenols and flavonoids is mainly influenced by edaphic, climatic, habitat, quantity, and quality of water available to the plants as stated by Li et al. [54]. The active biological compounds that exist within the medicinal plant extract that was chosen for the research and that show positive outcomes for the constituents analyzed can be best estimated with the help of phytochemical analysis. These possess a medicinal role, which is essential in maintaining the stability of human physiology. The extracts of S. petiolata in crude extract and subfractions with a notable content of phytochemicals. It is highly effective in many biological activities and remedial signs [13]. The plants that were chosen to consist of an average amount of phenol, alkaloid, and flavonoids. These are excellent sources for different diseases and are essential for normal physiological activities of the human body, a finding agreed with Ghosh et al. [55].

3.3. ESI-LC-MS Assessment

Based on the most substantial abilities for the observed biological activities the most active SPM extract was profiled to identify the promising bioactive ingredients tentatively. The tested sample contains 19 compounds signifying four groups: flavonoids (10), alkaloids (3), terpenoids (5), and phenols (1), among which, 9 compounds were detected in negative ionization mode (NIM) among, and 10 bioactive compounds were observed in positive ionization mode (PIM). The Full Scan chromatograms of negative ionization mode and positive ionization mode and chromatograms of the respective compounds are given in Figures S1 and S2.
Flavonoids were noted as a major group and contributed ten (10) compounds among which six (6) compounds (2, 4, 6, 7, 8, and 12) were identified in NIM, while four compounds (15, 16, 17, and 18) were observed in PIM as displayed in Table 3 and Figure 1. These compounds were reported for the first time from S. petiolata while earlier reported from S. altissima, S. baicalensis, S. barbata [56,57,58], S. baicalensis [59] S.multicaulis [60] S. prostrata [32,61] S. barbata [62] S. multicaulis and S. patonii [60] and possess the promising potential to resist the human pathogenic microbes, scavenge the free radicals treat inflammation [63,64,65].
In addition to that five terpenoids (9, 10, 11, 13, and 14) were observed in PIM in the most active extract previously reported from S. drummondii, S. rubicunda, and S. barbata [62,66,67] having the therapeutic significance to act as an antioxidant, antibacterial, and anti-inflammatory agent [32,68,69]. The SPM contains three alkaloids two compounds (1 and 3) were noticed in NIM and one compound (5) was observed in PIM previously reported from S. flavescens [70] and is well-known for its antioxidant, antimicrobial, anti-allergenic, analgesic, and anti-inflammatory [71,72,73], while one compound 19 observed in PIM was representing the phenolic group which was previously reported from S. baicalensis [74] and can inhibit microbial growth [75].

3.4. Antimicrobial Potential

3.4.1. Antibacterial Significance

The local practices were validated due to the current antibacterial assessment utilizing S. petiolata in various fractions as represented in Figure 2. The highest resistance against the Gram-negative bacterial strain S. typhi was demonstrated by the SPM extract with 17.8 ± 0.04 mm zone of inhibition (ZOI), proceeded with 17.2 ± 0.02 mm and 16.8 ± 0.04 mm ZOI by the SPDCM and SPNH fractions respectively, while the least resistance was offered by the aqueous extract with 16.4 ± 0.03 mm from low to high dose. Furthermore, the SPM, SPDCM, SPNH, and SPAQ extract presented 18.8 ± 0.04, 17.3 ± 0.02, 16.6 ± 0.01, and 14.3 ± 0.03 mm ZOI against the K. pneumonia correspondingly as compared to levofloxacin which exhibited 23.6 ± 0.02 and 21.3 ± 0.04 mm ZOI against the S. typhi and K. pneumonia correspondingly. In addition to that, the same SPM extract presented 19.4 ± 0.01 mm ZOI, followed by the SPDCM and SPNH fraction with 18.7 ± 0.02 and 17.6 ± 0.01 mm ZOI against the Gram-positive bacterial strains B. atrophaeus while the aqueous extract revealed the least inhibition of 16.2 ± 0.04 mm ZOI in comparison to erythromycin with 21.8 ± 0.03 mm ZOI. The antibacterial significance of the selected plant might be due to the presence of flavonoids as stated by Cushnie et al. [78] and Gorniak et al. [79]. The genus Scutellaria also contains phenols that have antibacterial capacities as documented by Cueva et al. [80]. Moreover, the tested samples SPM, SPDCM, SPNH, and SPAQ offered 18.8 ± 0.04, 18.2 ± 0.02, 17.4 ± 0.04, and 16.6 ± 0.02 mm ZOI against B. subtilis as compared to standard having 23.2 ± 0.05 mm ZOI. The recent studies uncovered that significant inhibition was exhibited against the Gram-positive bacterial strains as compared to the Gram-negative bacterial strains consented with the findings of Shah et al. [2] which screened S. edelbergii and also the literature stated by Leach et al. [81] for S. baicalensis. Our recent data was not equated to the findings of Arituluk et al. [82], Yilmaz et al. [26], and Ordan et al. [83] for some Scutellaria species.

3.4.2. Antifungal Significance

The antifungal significance of the selected plant in various fractions was tested and reflected appreciable outcomes as displayed in Figure 3. The SPDCM extract presented the maximum resistance of 19.07 ± 0.02 mm, followed by the SPM and SPNH fractions of 19.07 ± 0.02 mm and 16.03 ± 0.01 mm ZOI respectively against the A. parasiticus while the least inhibition among the tested samples were offered by the aqueous extract with 15.11 ± 0.04 mm in comparison to fluconazole with 20.8 ± 0.05 mm ZOI. Furthermore, the SPDCM, extract exhibited 18.87 ± 0.04 mm ZOI proceeded by the SPM, SPNH, and SPAQ extract with 18.21 ± 0.03, 15.81 ± 0.01 and 14.51 ± 0.01 mm, respectively, in comparison to the standard with 21.5 ± 0.02 mm zone of inhibition. The antifungal activity of the selected plant in various fractions might be due to the presence of an abundant quantity of flavonoids and phenols as stated by Simonetti et al. [84] and Galeotti et al. [85]. Moreover, our recent data are not similar to the literature stated by Shah et al. [2] and Da et al. [86] might be due to the presence of less amount of the secondary metabolites that are reported for the antifungal significance. Our study consented to the findings of Kasaian et al. [69] and Zhao et al. [87] for some species of the genus Scutellaria. The same genus Scutellaria contains similar compounds that can resist fungal growth.

3.5. Antioxidant Capacity

Synthetic free radical (2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid)) (ABTS) and DPPH tests were used to determine the antioxidant properties of the S. petiolata extract and fraction (Figure 4 and Figure 5). In DPPH, the MeOH extract had the maximum antioxidant capacity, with IC50 = 78.75 ± 0.19 µg/mL followed by the DCM, n-Hexane, and aqueous fraction which offered an IC50 = 140.50 ± 0.20, 192.70 ± 0.15, and 283.10 ± 0.24 µg/mL free radicals scavenging capacities, respectively. In addition to that, in the ABTS assay, the same MeOH extract presented an IC50 = 85.91 ± 0.24 µg/mL proceeded by the DCM, n-Hexane, and aqueous fractions having IC50 = 182.50 ± 0.35, 224.50 ± 0.13, and 317.40 ± 0.26 µg/mL. It was observed that the n-Hexane fractions were found to be the least active in both ABTS and DPPH assays.
The standard utilized ascorbic acid, which had IC50 values of 67.14 ± 0.25 and 69.96 ± 0.18 µg/mL in the DPPH and ABTS assays, correspondingly. The capability to neutralize the free radicals is mainly attributed to the flavonoids and phenolic contents as stated by Yakoub et al. [88] which are the dominant group of bioactive ingredients of the genus Scutellaria Malikov et al. [89] and Pei et al. [90]. Several bioactive compounds mainly phenols and flavonoids were extracted from Citrus limon L having the capacity to act as antioxidant agents as documented by Imeneo et al. [91]
The intake of juicy food supplements has the promising capabilities to neutralize the free radicals as stated by Giuffre et al. [92]. The plants with high contents of phenols and flavonoids also offered substantial antioxidant potential as described by Kodama et al. [93]. The current studies reveal that our findings matched with the data stated by Shah et al. [2] and also consented to the data reported earlier by Bazzaz et al. [94] for S. litwinowii. Furthermore, it was reflected in previous studies stated by Yang et al. [47] that the plant from the same genus varies in the contents of the responsible bioactive compounds. Thus the outcomes confirmed by Georgieva et al. [95] and Saboura et al. [96] from some Scutellaria plant species showed a slight variation as compared to our findings as the edaphic, climatic, and environmental factors alter the composition of the chemical ingredients in plants.

3.6. In Vivo Activities

The selected plant in various extracts was tested to screen their capacity for the treatment to cure inflammation and analgesic significance.

3.6.1. Anti-Inflammatory Significance

The anti-inflammatory effect of S. petiolata in various extracts is presented in Table 4. The carrageenan-induced assay was used to test the anti-inflammatory properties of extracts in Swiss albino mice. Compared to the other extracts that were examined, the SPM fraction was potent 55.14% inhibition cure inflammation, followed by the SPDCM and SPNH with 53.67% and 40.44% inhibitory potential correspondingly. The aqueous fraction, on the other hand, had the least activity 38.97% inhibition. However, conventional diclofenac sodium presented 70.58% inhibition in the experimental used animals is displayed in Table 4. The anti-inflammatory significance of the understudy sample was attributed to the presence of phenolic and flavonoid constituents as stated by Lu et al. [97] and Calvin et al. [98]. Our findings are consistent with those of Lee et al. [99], Liu et al. [51], and Shah et al. [2], who used a similar approach and fractions to explore S. baicalensis, S. barbata, and S. edelbergii respectively. All these plants belong to the same genus and mainly the plant species of the same genus probably contain the same responsible constituents. Our data are inconsistent with the information reported for some Scutellaria species, as stated by Varmuzova et al. [100] and Han et al. [101]. The variation among the anti-inflammatory might be due to the approaches used and constituents variation among the plant’s species.

3.6.2. Analgesic Potential

Table 5 indicates the analgesic effect of S. petiolata extract and sub-fractions in Swiss albino mice. With 50.88% inhibition, the SPM fraction had the most analgesic efficacy, followed by SPDCM and SPNH fractions with 46.64% and 42.04% inhibition respectively. The aqueous fraction, on the other hand, presented the least with 38.86% inhibition as shown in Table 5. Aspirin was utilized as a standard, and it inhibited writhes generated by acetic acid by 62.19% inhibition. Furthermore, the previous studies stated by Malikov et al. [89] reflected the genus Scutellaria plants species contain phenols and flavonoids in maximum quantity. Our findings are consistent with those of Shah et al. [2] for S. edelbergii, Lee et al. [99] and Yimam et al. [102] who used similar methods and plant species S. baicalensis of the same genus Scutellaria. However, our current data does not support the results presented by Uritu et al. [33] and Delazar et al. [103], who screened some plants of the family Lamiaceae to find out their analgesic capacities. The variation among the outcomes might be due to the use of an increased dose of plant extracts, genus and variations among the environmental gradients that alter the composition of the secondary metabolites, as stated by Borges et al. [104].

4. Conclusions

It is concluded that S. petiolata contains responsible bioactive ingredients with a variety of phytochemicals with a lot of biological properties that might be responsible for its several therapeutic effects. All the tested samples in general and the SPM extract in, have the highest flavonoids and phenolic contents. A total of nineteen bioactive compounds were reported for the first time from S. petiolata, among which flavonoids and terpenoids were the dominant groups. Appreciable antimicrobial activity was presented in SPM and SPDCM against the bacterial and fungal strains. The SPM extracts among the screened samples were potent for the DPPH and ABTS free radicals scavenging capacities. The SPM and SPDCMS extracts were observed efficient to cure inflammation and relieve pain in the experimental used Swiss albino mice. Hence, it was concluded that S. petiolata might be employed to resist the microbes, scavenge the free radicals, for the treatment of inflammation and pain (analgesic.) These properties are attributed due to the presence of flavonoids and triterpenoids. Still, further investigations are suggested/recommended to screen and isolate the potential chemical ingredients for the examined complications.

Supplementary Materials

The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/antiox11081446/s1, Figure S1: Full-scan ESI-LC-MS chromatogram of the methanol extract of S. petiolata. (A) Mass spectra of NIM and (B) Mass spectra of PIM. Figure S2: Chromatograms of the respective tentatively identified via ESI-LC-MS analysis in the MeOH extract of S. petiolata.

Author Contributions

S.M., M.S., R.A. and W.M. designed the project and wrote the original manuscript. N.U.R. and M.S performed the ESI-LC-MS analysis, phytochemical screening, and interprets the data. While S.M., M.S. and N.U.R. conducted the in vitro and in vivo activities. R.A., W.M. and A.A.-H. supervised the project and assisted in reviewing and editing the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by The Oman Research Council (TRC) through the funded project (BFP/RGP/CBS/21/002). The APC was funded by the same project.

Institutional Review Board Statement

The study was completed as per the given guidance of ARRIVE recommendation authorized by the ethical committee with Reference No (AWKUM/Bot/2018/1679, Dated: 8 November 2018) of Abdul WaliKhan University Mardan, Mardan (AWKUM).

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available in article and supplementary material.

Acknowledgments

The authors would also like to give sincere appreciations to the Oman Research Council (TRC) through the funded project (BFP/RGP/CBS/21/002) and Natural and Medical Sciences Research Center, University of Nizwa, Nizwa, Oman for providing lab facilities.

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of the compounds are not available from the authors.

References

  1. Kabir, M.T.; Rahman, M.H.; Shah, M.; Jamiruddin, M.R.; Basak, D.; Al-Harrasi, A.; Bhatia, S.; Ashraf, G.M.; Najda, A.; El-Kott, A.F. Therapeutic promise of carotenoids as antioxidants and anti-inflammatory agents in neurodegenerative disorders. Biomed. Pharmacother. 2022, 146, 112610. [Google Scholar] [CrossRef] [PubMed]
  2. Shah, M.; Murad, W.; Ur Rehman, N.; Halim, S.A.; Ahmed, M.; Rehman, H.; Zahoor, M.; Mubin, S.; Khan, A.; Nassan, M.A. Biomedical Applications of Scutellaria edelbergii Rech. f.: In vitro and in vivo Approach. Molecules 2021, 26, 3740. [Google Scholar] [CrossRef]
  3. Ullah, A.; Munir, S.; Badshah, S.L.; Khan, N.; Ghani, L.; Poulson, B.G.; Emwas, A.-H.; Jaremko, M. Important flavonoids and their role as a therapeutic agent. Molecules 2020, 25, 5243. [Google Scholar] [CrossRef]
  4. Soobrattee, M.A.; Neergheen, V.S.; Luximon-Ramma, A.; Aruoma, O.I.; Bahorun, T. Phenolics as potential antioxidant therapeutic agents: Mechanism and actions. Mut. Res. Fund. Mol. Mechan. Mutag. 2005, 579, 200–213. [Google Scholar] [CrossRef]
  5. A Rane, R.; Jain, K.; Shaikh, M.; Hampannavar, G.; Karpoormath, R. A recent perspective on discovery and development of diverse therapeutic agents inspired from isatin alkaloids. Curr. Top. Med. Chem. 2016, 16, 1262–1289. [Google Scholar] [CrossRef]
  6. Joshi, B.; Lekhak, S.; Sharma, A.J.S. Antibacterial property of different medicinal plants: Ocimum sanctum, Cinnamomum zeylanicum, Xanthoxylum armatum and Origanum majorana. Kathmandu Univ. J. Sci. Eng. Technol. 2009, 5, 143–150. [Google Scholar] [CrossRef] [Green Version]
  7. Okwu, D.E. Phytochemical and vitamin content of indigenous spices of South Eastern Nigeria. J. Sustain. Agric. Environ. 2004, 6, 30–34. [Google Scholar]
  8. Edeoga, H.; Eriata, D.O. Alkaloid, tannin and saponin contents of some Nigeria medicinal plants. J. Med. Aromatic. Plant Sci. 2001, 23, 344–349. [Google Scholar]
  9. Nazir, N.; Jan, M.R.; Ali, A.; Asif, M.; Idrees, M.; Nisar, M.; Zahoor, M.; Abd El-Salam, N.M.J. Prevalence of hepatitis-C virus genotypes and potential transmission risks in Malakand Khyber Pakhtunkhwa, Pakistan. Virol. J. 2017, 14, 1–9. [Google Scholar] [CrossRef] [Green Version]
  10. Shah, M.; Rahman, H.; Khan, A.; Bibi, S.; Ullah, O.; Ullah, S.; Ur Rehman, N.; Murad, W.; Al-Harrasi, A. Identification of α-Glucosidase Inhibitors from Scutellaria edelbergii: ESI-LC-MS and Computational Approach. Molecules 2022, 27, 1322. [Google Scholar] [CrossRef]
  11. Singh, R.; Sawhney, S. Advances in Frontier Areas of Plant Biochemistry; Prentice-Hall of India Private Limited: Hoboken, NJ, USA, 1988; p. 581-19200000. [Google Scholar]
  12. Rein, D.; Paglieroni, T.G.; Wun, T.; Pearson, D.A.; Schmitz, H.H.; Gosselin, R.; Keen, C.L.C. Cocoa inhibits platelet activation and function. Am. J. Clin. Res. 2000, 72, 30–35. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Farooq, U.; Waseem, B.; Muzaffar, R.; Tripathi, J.; Tharani, M.; Sharma, M. A comparative study of phytochemical investigation of Xanthium strumarium medicinal plant. Int. J. Res. Pharm. Chem. 2014, 4, 96–100. [Google Scholar]
  14. Osuagwu, G.; Okwulehie, I.; Emenike, J.J.S. Phytochemical and Mineral content of the leaves of four Nigerian Pterocarpus species. Int. J. Mol. Med. Adv. Sci. 2007, 3, 6–11. [Google Scholar]
  15. Okwu, D.J.G.P.; Sciences, A. Evaluation of chemical composition of indeginous species and flavouring agents. Glob. J. Pure Appl. Sci. 2001, 7, 455–460. [Google Scholar] [CrossRef]
  16. Kumar, M.; Prasad, S.K.; Hemalatha, S.J.P.R. A current update on the phytopharmacological aspects of Houttuynia cordata Thunb. Pharmacogn. Rev. 2014, 8, 22. [Google Scholar] [PubMed] [Green Version]
  17. Falcone, M.; Paterson, D. Spotlight on ceftazidime/avibactam: A new option for MDR Gram-negative infections. J. Antimicrob. Chemother. 2016, 71, 2713–2722. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  18. Fair, R.; Tor, Y. Antibiotics and bacterial resistance in the 21st century. Perspect. Med. Chem. 2014, 6, 25–64. [Google Scholar] [CrossRef] [Green Version]
  19. Bakal, S.N.; Bereswill, S.; Heimesaat, M.M. Finding novel antibiotic substances from medicinal plants antimicrobial properties of Nigella sativa directed against multidrug resistant bacteria. Eur. J. Microbiol. Immunol. 2017, 7, 92–98. [Google Scholar] [CrossRef] [Green Version]
  20. Yu, M.; Gouvinhas, I.; Rocha, J.; Barros, A.I. Phytochemical and antioxidant analysis of medicinal and food plants towards bioactive food and pharmaceutical resources. Sci. Rep. 2021, 11, 1–14. [Google Scholar] [CrossRef]
  21. Akhtar, M.F.; Saleem, A.; Hamid, I.; Alsharif, K.F.; Abdel-Daim, M.M.; Rahman, M.H.; Shah, M.; Sohail, K.; Javaid, Z. Contemporary uses of old folks: The immunomodulatory and toxic potential of fenbufen. Cell. Mol. Biol. 2021, 67, 27–37. [Google Scholar] [CrossRef]
  22. Akhtar, M. Anti-inflammatory Medicinal Plants of Bangladesh–A Pharmacological Evaluation. Front. Pharmacol. 2022, 3, 464–467. [Google Scholar] [CrossRef] [PubMed]
  23. Chopra, H.; Dey, P.S.; Das, D.; Bhattacharya, T.; Shah, M.; Mubin, S.; Maishu, S.P.; Akter, R.; Rahman, M.; Karthika, C. Curcumin Nanoparticles as Promising Therapeutic Agents for Drug Targets. Molecules 2021, 26, 4998. [Google Scholar] [CrossRef]
  24. Attiq, A.; Jalil, J.; Husain, K.; Ahmad, W. Raging the war against inflammation with natural products. Front. Pharmacol. 2018, 9, 976–979. [Google Scholar] [CrossRef] [PubMed]
  25. Arulselvan, P.; Fard, M.T.; Tan, W.S.; Gothai, S.; Fakurazi, S.; Norhaizan, M.E.; Kumar, S.S. Role of antioxidants and natural products in inflammation. Oxid. Med. Cell. Longev. 2016, 2, 15–21. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Yilmaz, G.; Simsek, D.; Altanlar, N.; Cicek, M. Comparison of the antimicrobial activity of some Scutellaria orientalis L. taxa growing in Turkey. Int. J. Second. Metab. 2020, 7, 192–199. [Google Scholar] [CrossRef]
  27. Shi, G.-X.; Shao, J.; Wang, T.-M.; Wang, C.Z.M. New advance in studies on antimicrobal activity of Scutellaria baicalensis and its effective ingredients. China J. Chin. Mat. Med. 2014, 39, 3713–3718. [Google Scholar]
  28. Bruno, M.; Piozzi, F.; Rosselli, S. Natural and hemisynthetic neoclerodane diterpenoids from Scutellaria and their antifeedant activity. Nat. Prod. Rep. 2002, 19, 357–378. [Google Scholar] [CrossRef]
  29. Rahman, M.U.; Muhammad, Z.; Ullah, A.; Ullah, R.; Ullah, T.; Jelani, G.; Ali, S.G.; Khan, W.M.; Ali, H. Phytogeographical And Ecological Studies Of The Endemic Flora of Zaini Valley Chitral, Hindukush Range, Pakistan. Wulfania J. 2020, 27, 1–10. [Google Scholar]
  30. Khan, K.R.; Iqbal, Z.; Alam, J.; Farooq, M.; Shah, A.H.; Hussain, M.; Shah, G.M.; Ali, D. Comparative study on floristic diversity of protected and unprotected Forests of Sathan Gali, District Mansehra, KP, Pakistan. Acta Ecol. Sin. 2019, 39, 273–279. [Google Scholar] [CrossRef]
  31. Hussain, W.; Badshah, L.; Asghar, A.; Hussain, F. Vincetoxicum cardiostephanum a threatened sub-endemic species in Koh-e-Safaid range, Pakistan. Biol. Diver. Conser. 2019, 13, 19–26. [Google Scholar] [CrossRef]
  32. Shang, X.; He, X.; He, X.; Li, M.; Zhang, R.; Fan, P.; Zhang, Q.; Jia, Z. The genus Scutellaria an ethnopharmacological and phytochemical review. J. Ethnopharmacol. 2010, 128, 279–313. [Google Scholar] [CrossRef] [PubMed]
  33. Uritu, C.M.; Mihai, C.T.; Stanciu, G.-D.; Dodi, G.; Alexa-Stratulat, T.; Luca, A.; Leon-Constantin, M.-M.; Stefanescu, R.; Bild, V.; Melnic, S.J.P.R. Management, Medicinal plants of the family Lamiaceae in pain therapy: A review. Pain Res. Manag. 2018, 2018, 1–44. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Gupta, D.; Dubey, J.; Kumar, M. Phytochemical analysis and antimicrobial activity of some medicinal plants against selected common human pathogenic microorganisms. Asian Pac. J. Trop. Dis. 2016, 6, 15–20. [Google Scholar] [CrossRef]
  35. Ali, H.; Qaiser, M. The ethnobotany of Chitral valley, Pakistan with particular reference to medicinal plants. Pak. J. Bot. 2009, 41, 2009–2041. [Google Scholar]
  36. Auwal, M.S.; Saka, S.; Mairiga, I.A.; Sanda, K.A.; Shuaibu, A.; Ibrahim, A. In Preliminary phytochemical and elemental analysis of aqueous and fractionated pod extracts of Acacia nilotica (Thorn mimosa). Vet. Res. Forum Int. Quart. J. 2014, 2, 95. [Google Scholar]
  37. Gacem, M.A.; Telli, A.; Gacem, H.; Ould-El-Hadj-Khelil, A. Phytochemical screening, antifungal and antioxidant activities of three medicinal plants from Algerian steppe and Sahara (preliminary screening studies). Appl. Sci. 2019, 1, 1721. [Google Scholar] [CrossRef] [Green Version]
  38. Sankhalkar, S.; Vernekar, V. Quantitative and Qualitative analysis of Phenolic and Flavonoid content in Moringa oleifera Lam and Ocimum tenuiflorum L. Pharmacogn. Res. 2016, 8, 16. [Google Scholar] [CrossRef] [Green Version]
  39. Khan, I.; Rahman, H.; El-Salam, A.; Nasser, M.; Tawab, A.; Hussain, A.; Khan, T.A.; Khan, U.A.; Qasim, M.; Adnan, M. Punica granatum peel extracts: HPLC fractionation and LC-MS analysis to quest compounds having activity against multidrug resistant bacteria. BMC Complement. Altern. Med. 2017, 17, 1–6. [Google Scholar] [CrossRef]
  40. Cazella, L.N.; Glamoclija, J.; Sokovic, M.; Goncalves, J.E.; Linde, G.A.; Colauto, N.B.; Gazim, Z.C. Antimicrobial activity of essential oil of Baccharis dracunculifolia DC (Asteraceae) aerial parts at flowering period. Front. Plant Sci. 2019, 2, 27. [Google Scholar] [CrossRef] [Green Version]
  41. Shah, M.; Murad, W.; Ur Rehman, N.; Mubin, S.; Al-Sabahi, J.N.; Ahmad, M.; Zahoor, M.; Ullah, O.; Waqas, M.; Ullah, S. GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In vitro, in vivo, and in silico approach. Molecules 2021, 26, 7676. [Google Scholar] [CrossRef]
  42. Kedare, S.B.; Singh, R. Genesis and development of DPPH method of antioxidant assay. J. Food Sci. Technol. 2011, 48, 412–422. [Google Scholar] [CrossRef] [Green Version]
  43. Du Sert, N.P.; Ahluwalia, A.; Alam, S.; Avey, M.T.; Baker, M.; Browne, W.J.; Clark, A.; Cuthill, I.C.; Dirnagl, U.; Emerson, M. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol. 2020, 18, 300–411. [Google Scholar]
  44. Hosseini, S.H.; Sadeghi, Z.; Hosseini, S.V.; Bussmann, R.W. Ethnopharmacological study of medicinal plants in Sarvabad, Kurdistan province, Iran. J. Ethnopharmacol. 2022, 2, 114985. [Google Scholar] [CrossRef] [PubMed]
  45. Goyal, A.; Sharma, A.; Kaur, J.; Kumari, S.; Garg, M.; Sindhu, R.K.; Rahman, M.H.; Akhtar, M.F.; Tagde, P.; Najda, A. Bioactive-Based Cosmeceuticals: An Update on Emerging Trends. Molecules 2022, 27, 828. [Google Scholar] [CrossRef] [PubMed]
  46. Phuyal, N.; Jha, P.K.; Raturi, P.P.; Rajbhandary, S. Total phenolic, flavonoid contents, and antioxidant activities of fruit, seed, and bark extracts of Zanthoxylum armatum DC. Sci. World J. 2020, 3, 20–24. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Yang, L.; Wen, K.-S.; Ruan, X.; Zhao, Y.-X.; Wei, F.; Wang, Q. Response of plant secondary metabolites to environmental factors. Molecules 2018, 23, 762. [Google Scholar] [CrossRef] [Green Version]
  48. Griesser, M.; Weingart, G.; Schoedl-Hummel, K.; Neumann, N.; Becker, M.; Varmuza, K.; Liebner, F.; Schuhmacher, R.; Forneck, A.J.P. Biochemistry, Severe drought stress is affecting selected primary metabolites, polyphenols, and volatile metabolites in grapevine leaves (Vitis vinifera cv. Pinot noir). Plant Physiol. Biochem. 2015, 88, 17–26. [Google Scholar] [CrossRef]
  49. Metlen, K.L.; Aschehoug, E.T.; Callaway, R.M. Plant behavioural ecology: Dynamic plasticity in secondary metabolites. Plant Cell Environ. 2009, 32, 641–653. [Google Scholar] [CrossRef]
  50. Stepanova, A.Y.; Solov’eva, A.I.; Malunova, M.V.; Salamaikina, S.A.; Panov, Y.M.; Lelishentsev, A.A. Hairy Roots of Scutellaria spp.(Lamiaceae) as Promising Producers of Antiviral Flavones. Molecules 2021, 26, 3927. [Google Scholar] [CrossRef]
  51. Liu, H.-L.; Kao, T.-H.; Shiau, C.-Y.; Chen, B.-H.J.J. Analysis of Functional components in Scutellaria barbata D. Don with anti-inflammatory activity on RAW 264.7 cells. J. Food Drug Anal. 2018, 26, 31–40. [Google Scholar] [CrossRef] [Green Version]
  52. Park, C.H.; Kim, Y.S.; Li, X.; Kim, H.H.; Arasu, M.V.; Al-Dhabi, N.A.; Lee, S.Y.; Park, S.U. Influence of different carbohydrates on flavonoid accumulation in hairy root cultures of Scutellaria baicalensis. Nat. Prod. Commun. 2016, 11, 578–625. [Google Scholar] [CrossRef] [Green Version]
  53. Chen, S.; Yuan, Y.; Luo, Y.; Huang, L.; Chen, P.; Li, X. Effects of light on flavonoids accumulation and related gene expression in suspension cultures of Scutellaria baicalensis. China J. Chin. Mat. Med. 2010, 35, 682–685. [Google Scholar]
  54. Li, Y.; Kong, D.; Fu, Y.; Sussman, M.R.; Wu, H. The effect of developmental and environmental factors on secondary metabolites in medicinal plants. Plant Physiol. Biochem. 2020, 148, 80–89. [Google Scholar] [CrossRef] [PubMed]
  55. Ghosh, P.; Mandal, A.; Chakraborty, P.; Rasul, M.; Chakraborty, M.; Saha, A. Triterpenoids from Psidium guajava with biocidal activity. Indian J. Pharm. Sci. 2010, 72, 504. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. Tomimori, T.; Miyaichi, Y.; Imoto, Y.; Kizu, H.; Namba, T. Studies on the Nepese Crude Drugs. VI.: On the Flavonoid Constituents of the Root of Scutellaria discolor Colebr. Chem. Pharm. Bull. 1986, 34, 406–408. [Google Scholar] [CrossRef] [Green Version]
  57. Takagi, S.; Yamaki, M.; Inoue, K. Studies on the water-soluble constituents of the roots of Scutellaria baicalensis Georgi (Wogon). J. Pharm. Soc. Jpn. 1980, 100, 1220–1224. [Google Scholar] [CrossRef]
  58. Zhang, C.; Zhang, Y.; Chen, J.; Liang, X. Purification and characterization of baicalin-β-D-glucuronidase hydrolyzing baicalin to baicalein from fresh roots of Scutellaria viscidula Bge. Process Biochem. 2005, 40, 1911–1915. [Google Scholar] [CrossRef]
  59. Tomimori, T.; Miyaichi, Y.; Kizu, H. On the flavonoid constituents from the roots of Scutellaria baicalensis Georgi. I. J. Pharm. Soc. Jpn. 1982, 102, 388–391. [Google Scholar] [CrossRef] [Green Version]
  60. Dehkordi, F.J.; Kharazian, N.; Lorigooini, Z. Characterization of flavonoid components in Scutellaria L. Species (Lamiaceae) using finger-printing analysis. Acta Biol. Crac. Bot. 2020, 3, 79–96. [Google Scholar]
  61. Kikuchi, Y.; Miyaichi, Y.; Tomimori, T. Studies on the Nepalese Crude Drugs. XIII. On the Flavonoid and Iridoid Constituents of the Root of Scutellaria grossa Wall. Chem. Pharm. Bull. 1991, 39, 1051–1054. [Google Scholar] [CrossRef] [Green Version]
  62. Dai, S.-J.; Tao, J.-Y.; Liu, K.; Jiang, Y.T.; Shen, L. Neo-Clerodane diterpenoids from Scutellaria barbata with cytotoxic activities. Phytochemistry 2006, 67, 1326–1330. [Google Scholar] [CrossRef] [PubMed]
  63. Shen, X.; Liu, Y.; Luo, X.; Yang, Z. Advances in biosynthesis, pharmacology, and pharmacokinetics of pinocembrin, a promising natural small-molecule drug. Molecules 2019, 24, 2323. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Wang, J.-F.; Liu, S.-S.; Song, Z.-Q.; Xu, T.-C.; Liu, C.-S.; Hou, Y.-G.; Huang, R.; Wu, S.-H. Naturally occurring flavonoids and isoflavonoids and their microbial transformation: A review. Molecules 2020, 25, 5112. [Google Scholar] [CrossRef] [PubMed]
  65. Mangoyi, R.; Midiwo, J.; Mukanganyama, S. Isolation and characterization of an antifungal compound 5-hydroxy-7, 4’-dimethoxyflavone from Combretum zeyheri. BMC Complement. Altern. Med. 2015, 15, 405. [Google Scholar] [CrossRef] [Green Version]
  66. Esquivel, B.; Flores, E.; Hernandez-Ortega, S.; Toscano, R.A. Neo-clerodane diterpenoids from Scutellaria drummondii. Phytochemistry 1995, 38, 175–179. [Google Scholar] [CrossRef]
  67. Bruno, M.; Piozzi, F.; Maggio, A.M.; Simmonds, M.S. Antifeedant activity of neoclerodane diterpenoids from two Sicilian species of Scutellaria. Biochem. Syst. Ecol. 2002, 8, 793–799. [Google Scholar] [CrossRef]
  68. Bardakci, H.; Skaltsa, H.; Milosevic-Ifantis, T.; Lazari, D.; Hadjipavlou-Litina, D.; Yeşilada, E.; Kırmızıbekmez, H. Antioxidant activities of several Scutellaria taxa and bioactive phytoconstituents from Scutellaria hastifolia L. Indus. Crops Prod. 2015, 77, 196–203. [Google Scholar] [CrossRef]
  69. Kasaian, J.; Alesheikh, P.; Mohammadi, A. Chemical Compositions and Biological Activities of Scutellaria genus Essential Oils (Lamiaceae). Jundishapur J. Nat. Pharm. Prod. 2020, 15, 21–27. [Google Scholar] [CrossRef]
  70. Ma, S.C.; Du, J.; But, P.P.-H.; Deng, X.L.; Zhang, Y.W.; Ooi, V.E.-C.; Xu, H.-X.; Lee, S.H.S.; Lee, S.F. Antiviral Chinese medicinal herbs against respiratory syncytial virus. J. Ethnopharm. 2002, 79, 205–211. [Google Scholar] [CrossRef]
  71. Krishna, P.M.; Knv, R.; Banji, D. A review on phytochemical, ethnomedical and pharmacological studies on genus Sophora, Fabaceae. Rev. Bras. De Farmacogn. 2012, 22, 1145–1154. [Google Scholar] [CrossRef] [Green Version]
  72. Liu, Y.; Xu, Y.; Ji, W.; Li, X.; Sun, B.; Gao, Q.; Su, C. Anti-tumor activities of matrine and oxymatrine: Literature review. Tumor Biol. 2014, 35, 5111–5119. [Google Scholar] [CrossRef] [PubMed]
  73. Gao, Y.; Li, G.; Li, C.; Zhu, X.; Li, M.; Fu, C.; Li, B. Anti-nociceptive and anti-inflammatory activity of sophocarpine. J. Ethnopharmacol. 2009, 125, 324–329. [Google Scholar] [CrossRef] [PubMed]
  74. Zhou, Z.H.; Zhang, Y.J.; Yang, C.-R. New flavonoid glycosides from Scutellaria amoena. Stud. Plant Sci. 1999, 6, 305–310. [Google Scholar]
  75. Calis, I.; Kirmizibekmez, H.; Beutler, J.A.; Donmez, A.A.; Yalçin, F.N.; Kilic, E.; Ozalp, M.; Ruedi, P.; Tasdemir, D. Secondary metabolites of Phlomis viscosa and their biological activities. Turk. J. Chem. 2005, 29, 71–82. [Google Scholar]
  76. Li, Y.; Chen, L.; Pu, R.; Zhou, L.; Zhou, X.; Li, X. Effects of a matrine-and sophoridine-containing herbal compound medicine (AH-05) on liver cancer. Nat. Prod. Commun. 2020, 15, 209–352. [Google Scholar] [CrossRef]
  77. Hussain, H.; Ahmad, V.U.; Anwar, S.; Miana, G.A.; Krohn, K. Chemical constituents of Scutellaria linearis. Biochem. Syst. Ecol. 2008, 5, 490–492. [Google Scholar] [CrossRef]
  78. Cushnie, T.T.; Lamb, A.J. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents 2005, 26, 343–356. [Google Scholar] [CrossRef]
  79. Górniak, I.; Bartoszewski, R.; Kroliczewski, J. Comprehensive review of antimicrobial activities of plant flavonoids. Phytochem. Rev. 2019, 18, 241–272. [Google Scholar] [CrossRef] [Green Version]
  80. Cueva, C.; Moreno-Arribas, M.V.; Martín-Álvarez, P.J.; Bills, G.; Vicente, M.F.; Basilio, A.; Rivas, C.L.; Requena, T.; Rodríguez, J.M.; Bartolomé, B. Antimicrobial activity of phenolic acids against commensal, probiotic and pathogenic bacteria. Res. Microbiol. 2010, 161, 372–382. [Google Scholar] [CrossRef]
  81. Leach, F.S. Anti-microbial properties of Scutellaria baicalensis and Coptis chinensis, two traditional Chinese medicines. Biosci. Horiz. 2011, 4, 119–127. [Google Scholar] [CrossRef] [Green Version]
  82. Arituluk, Z.C.; Ozkul Kocak, C.; Renda, G.; Ekizoglu, M.; Ezer, N. Antimicrobial activity of three Scutellaria L. species from Turkey. J. Res. Pharm. 2019, 23, 552–558. [Google Scholar] [CrossRef] [Green Version]
  83. Ordon, M.; Nawrotek, P.; Stachurska, X.; Schmidt, A.; Mizielińska, M. Mixtures of Scutellaria baicalensis and Glycyrrhiza L. Extracts as Antibacterial and Antiviral Agents in Active Coatings. Coatings 2021, 11, 1438. [Google Scholar] [CrossRef]
  84. Simonetti, G.; Brasili, E.; Pasqua, G. Antifungal activity of phenolic and polyphenolic compounds from different matrices of Vitis vinifera L. Against human pathogens. Molecules 2020, 25, 3748. [Google Scholar] [CrossRef] [PubMed]
  85. Galeotti, F.; Barile, E.; Curir, P.; Dolci, M.; Lanzotti, V. Flavonoids from carnation (Dianthus caryophyllus) and their antifungal activity. Phytochem. Lett. 2008, 1, 44–48. [Google Scholar] [CrossRef]
  86. Da, X.; Nishiyama, Y.; Tie, D.; Hein, K.Z.; Yamamoto, O.; Morita, E. Antifungal activity and mechanism of action of Ou-gon (Scutellaria root extract) components against pathogenic fungi. Sci. Rep. 2019, 9, 1–12. [Google Scholar] [CrossRef]
  87. Zhao, T.; Tang, H.; Xie, L.; Zheng, Y.; Ma, Z.; Sun, Q.; Li, X. Scutellaria baicalensis Georgi.(Lamiaceae): A review of its traditional uses, botany, phytochemistry, pharmacology and toxicology. J. Pharm. Pharmacol. 2019, 71, 1353–1369. [Google Scholar] [CrossRef] [Green Version]
  88. Yakoub, A.R.B.; Abdehedi, O.; Jridi, M.; Elfalleh, W.; Nasri, M.; Ferchichi, A. Flavonoids, phenols, antioxidant, and antimicrobial activities in various extracts from Tossa jute leave (Corchorus olitorus L.). Indus. Crops Prod. 2018, 118, 206–213. [Google Scholar] [CrossRef]
  89. Malikov, V.; Yuldashev, M. Phenolic compounds of plants of the Scutellaria L. genus. Distribution, structure, and properties. Chem. Nat. Compd. 2002, 38, 358–406. [Google Scholar] [CrossRef]
  90. Pei, T.; Yan, M.; Huang, Y.; Wei, Y.; Martin, C.; Zhao, Q. Specific Flavonoids and Their Biosynthetic Pathway in Scutellaria baicalensis. Front. Plant Sci. 2022, 13, 866282. [Google Scholar] [CrossRef]
  91. Imeneo, V.; Romeo, R.; De Bruno, A.; Piscopo, A. Green-sustainable extraction techniques for the recovery of antioxidant compounds from “Citrus Limon” by-products. J. Environ. Sci. Health 2022, 2, 1–13. [Google Scholar] [CrossRef]
  92. Giuffrè, A.M. Bergamot (Citrus bergamia, Risso): The effects of cultivar and harvest date on functional properties of juice and cloudy juice. Antioxidants 2019, 8, 221. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  93. Kodama, D.H.; Goncalves, A.E.S.; Lajolo, F.M.; Genovese, M.I. Flavonoids, total phenolics and antioxidant capacity: Comparison between commercial green tea preparations. Food Sci. Technol. 2010, 30, 1077–1082. [Google Scholar] [CrossRef] [Green Version]
  94. Bazzaz, B.F.; Khayat, M.H.; Emami, S.A.; Asili, J.; Sahebkar, A.; Neishabory, E.J. Antioxidant and antimicrobial activity of methanol, dichloromethane, and ethyl acetate extracts of Scutellaria litwinowii. Sci. Asia 2011, 37, 327–334. [Google Scholar] [CrossRef]
  95. Georgieva, Y.; Katsarova, M.; Stoyanov, P.; Mladenov, R.; Denev, P.; Teneva, D.; Plotnikov, E.; Bozov, P.; Dimitrova, S. Metabolite profile and antioxidant activity of some species of Genus Scutellaria growing in Bulgaria. Plants 2020, 10, 45. [Google Scholar] [CrossRef]
  96. Saboura, A.; Ahmadi, A.; Zeinali, A.; Parsa, M. Comparison between the contents of phenolic and flavonoid compounds and aerial part antioxidant activity in Scutellaria pinnatifida in two NorthIranian populations. J. Rafsanjan Univ. Med. Sci. 2014, 13, 249–266. [Google Scholar]
  97. Lu, C.L.; Zhu, W.; Wang, M.; Xu, X.; Lu, C.J. Antioxidant and anti-inflammatory activities of phenolic-enriched extracts of Smilax glabra. Evid. Based Complement. Altern. Med. 2014, 2014, 910438. [Google Scholar] [CrossRef]
  98. Clavin, M.; Gorzalczany, S.; Macho, A.; Munoz, E.; Ferraro, G.; Acevedo, C.; Martino, V. Anti-inflammatory activity of flavonoids from Eupatorium arnottianum. J. Ethnopharmacol. 2007, 112, 585–589. [Google Scholar] [CrossRef]
  99. Lee, J.-K.; Song, Y.-K.; Lim, H.-H. Analgesic and anti-inflammatory effect of Scutellaria baicalensis. J. Korean Med. 2007, 28, 124–135. [Google Scholar]
  100. Varmuzova, K.; Matulova, M.E.; Gerzova, L.; Cejkova, D.; Gardan-Salmon, D.; Panhéleux, M.; Robert, F.; Sisak, F.; Havlickova, H.; Rychlik, I. Curcuma and Scutellaria plant extracts protect chickens against inflammation and Salmonella enteritidis infection. Poult. Sci. 2015, 94, 2049–2058. [Google Scholar] [CrossRef]
  101. Han, Q.-T.; Ren, Y.; Li, G.-S.; Xiang, K.-L.; Dai, S.J. Flavonoid alkaloids from Scutellaria moniliorrhiza with anti-inflammatory activities and inhibitory activities against aldose reductase. Phytochemistry 2018, 152, 91–96. [Google Scholar] [CrossRef]
  102. Yimam, M.; Brownell, L.; Hodges, M.; Jia, Q. Analgesic effects of a standardized bioflavonoid composition from Scutellaria baicalensis and Acacia catechu. J. Diet. Suppl. 2012, 9, 155–165. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  103. Delazar, A.; Asl, B.H.; Mohammadi, O.; Afshar, F.H.; Nahar, L.; Modarresi, M.; Nazemiyeh, H.; Sarker, S.D. Evaluation of analgesic activity of Eremostachys laciniata in mice. J. Nat. Remedies 2009, 9, 1–7. [Google Scholar]
  104. Borges, C.V.; Minatel, I.O.; Gomez, H.A.; Lima, G.P.P. Medicinal plants: Influence of environmental factors on the content of secondary metabolites. Med. Plants Environ. Chall. 2017, 2, 259–277. [Google Scholar]
Figure 1. Structures of the tentatively identified compounds in SPM extract of S. petiolata.
Figure 1. Structures of the tentatively identified compounds in SPM extract of S. petiolata.
Antioxidants 11 01446 g001
Figure 2. Antibacterial activity of S. petiolata extracts, SP) S. petiolata, M = methanol extract, DCM = dichloromethane fraction, NH = n-Hexane fraction, AQ = aqueous fraction, DMSO = dimethyl sulfoxide, negative control and positive control = erythromycin and levofloxacin whereas, (A) antibacterial resistance against S. typhi, (B) K. pneumonia, (C) B. atrophaeus, (D) B. subtilis. All the data was taken in triplicate (n = 3) and analyzed through two-way ANOVA, via Tukey’s multiple comparison test, ns = >0.9999, p = **** <0.0001).
Figure 2. Antibacterial activity of S. petiolata extracts, SP) S. petiolata, M = methanol extract, DCM = dichloromethane fraction, NH = n-Hexane fraction, AQ = aqueous fraction, DMSO = dimethyl sulfoxide, negative control and positive control = erythromycin and levofloxacin whereas, (A) antibacterial resistance against S. typhi, (B) K. pneumonia, (C) B. atrophaeus, (D) B. subtilis. All the data was taken in triplicate (n = 3) and analyzed through two-way ANOVA, via Tukey’s multiple comparison test, ns = >0.9999, p = **** <0.0001).
Antioxidants 11 01446 g002
Figure 3. Antifungal activity was of S. petiolata crude extract and subfractions, SP = S. petiolata, SPM = methanol extract, SPDCM = dichloromethane fraction, SPNH = n-Hexane fraction, SPAQ = aqueous fraction, DMSO = dimethyl sulfoxide negative control and positive control fluconazole, However, (A) represent the antifungal significance against A. parasiticus and (B) A. niger. All the data was taken in triplicate (n = 3) and analyzed through two-way ANOVA, via Tukey’s multiple comparison test, ns = >0.9999, p = **** <0.0001.
Figure 3. Antifungal activity was of S. petiolata crude extract and subfractions, SP = S. petiolata, SPM = methanol extract, SPDCM = dichloromethane fraction, SPNH = n-Hexane fraction, SPAQ = aqueous fraction, DMSO = dimethyl sulfoxide negative control and positive control fluconazole, However, (A) represent the antifungal significance against A. parasiticus and (B) A. niger. All the data was taken in triplicate (n = 3) and analyzed through two-way ANOVA, via Tukey’s multiple comparison test, ns = >0.9999, p = **** <0.0001.
Antioxidants 11 01446 g003
Figure 4. Free radicals scavenging potential by the tested samples of S. petiolata using DDPH assay, where A represent SPM, B SPDCM, C SPNH, D SPAQ, and E standard ascorbic acid significance as an antioxidant agent.
Figure 4. Free radicals scavenging potential by the tested samples of S. petiolata using DDPH assay, where A represent SPM, B SPDCM, C SPNH, D SPAQ, and E standard ascorbic acid significance as an antioxidant agent.
Antioxidants 11 01446 g004
Figure 5. Antioxidant significance by the S. petiolata extracts using the ABTS assay, where A represent SPM, B SPDCM, C SPNH, D SPAQ, and E standard ascorbic acid significance as an antioxidant agent.
Figure 5. Antioxidant significance by the S. petiolata extracts using the ABTS assay, where A represent SPM, B SPDCM, C SPNH, D SPAQ, and E standard ascorbic acid significance as an antioxidant agent.
Antioxidants 11 01446 g005
Table 1. Qualitative detection of the phytochemical groups in S. petiolata extracts.
Table 1. Qualitative detection of the phytochemical groups in S. petiolata extracts.
Extracts UsedFlavonoidsPhenolsAlkaloidsCarbohydrates
SPM+-++
SPDCM+++-
SPNH ++--
SPAQ ++++
SP: Scutellaria petiolata, M: methanolic extract, DCM: dichloromethane fraction, NH: n-hexane fraction, and AQ: aqueous fraction, whereas + represents the presence and - shows the absence of the representative phytochemical group.
Table 2. Determination of the total flavonoids and phenols in S. petiolata extracts.
Table 2. Determination of the total flavonoids and phenols in S. petiolata extracts.
Extracts Used TFC (mg QE/mg)
Dry Fractions
Mean ± SEM
TPC (mg GAE/g)
Dry Fractions
Mean ± SEM
SPM78.2 ± 0.22 **66.2 ± 0.33 **
SPDCM67.4 ± 0.15 **61.5 ± 0.66 **
SPNH 46.2 ± 0.66 **38.4 ± 0.33 **
SPAQ 49.4 ± 0.37 **41.3 ± 0.33 **
SP: Scutellaria petiolata, M: methanolic extract, DCM: dichloromethane fraction, NH: n-Hexane fraction, AQ: aqueous fraction, TPC: total phenolic contents, TFC: total flavonoids, QE: quercetin equivalent, GAE: gallic acid equivalent, n: 3, p ≤ 0.01 **, mg: milligram, g: gram, the whole data expressed as Mean ± SEM (standard error mean).
Table 3. Compounds identified through ESI-LC-MS analysis in the active SPM extract.
Table 3. Compounds identified through ESI-LC-MS analysis in the active SPM extract.
NumberingRT (min)[M−H]/
[M+H]+ (m/z)
Tentative Identification Reference Species Classification
14.10247.08Sophoridine S. flavescens [76]Alkaloid
24.22255.25Pinocembrin S. altissima [56]Flavonoid
34.35263.08OxymatrineS. flavescens [70]Alkaloid
44.59287.17(tans)-5,7,2′,6′-TetrahydroxyflavanolsS. baicalensis [57]Flavonoid
54.62247.08Sophocarpine S. flavescens [70]Alkaloid
64.71297.255-Hydroxy-7,8-dimethoxyflavoneS. barbata [58]Flavonoid
74.86301.083,5,7,2,6-Pentahydroxy flavoneS.baicalensis [59]Flavonoid
85.20331.25Myricetin-3’-methyl ether S.multicaulis [60]Flavonoid
95.32393.302-Hydroxyajugarin VS. drummondii
[66]
Terpenoid
106.00489.50Scutegrossin A S. rubicunda [67]Terpenoid
116.10505.42Scutecyprol B S. rubicunda [67]Terpenoid
126.36359.205,6,2-Trihydroxy-7,8,6-trimethoxy flavone S. prostrata [32]Flavonoid
136.62531.50Scuterivulactone C2S. barbata [62]Terpenoid
147.18567.50Lupulin B S. linearis [77]Terpenoid
157.55575.50Barbatin AS. barbata [62]Flavonoid
167.80595.50Scutellarein-7-O-neohesperidosideS. multicaulis [60]Flavonoid
177.89611.58Quercetin-3-O-rutinoside S. patonii [60]Flavonoid
188.06495.33Scutellaprostin F S. prostrata [61]Flavonoid
198.24639.58Leucosceptoside A S. baicalensis [74]Phenol
Table 4. Anti-inflammatory significance of S. petiolata extracts.
Table 4. Anti-inflammatory significance of S. petiolata extracts.
TreatmentsChange in Paw Diameter (Mean ± SEM)
Dose Conc.after 1 hafter 2 hafter 3 hAver. Reading% Inhibition
Carrag.1 mL1.11± 0.031.33 ± 0.011.66 ± 0.021.36 ± 0.12
NS1 mL1.10 ± 0.021.31 ± 0.031.65 ± 0.011.35± 0.02-----
DS50 (mg/kg)0.50 ± 0.020.34 ± 0.050.18 ± 0.030.34 ± 0.0270.58
SPM500.91 ± 0.060.75 ± 0.030.62 ± 0.010.76 ± 0.03 *44.11
1000.74 ± 0.030.61 ± 0.020.49 ± 0.030.61 ± 0.02 *55.14
SPDCM500.89 ± 0.070.81 ± 0.010.70 ± 0.050.80 ± 0.05 *41.17
1000.76 ± 0.040.63 ± 0.020.51 ± 0.060.63 ± 0.04 *53.67
SPNH500.94 ± 0.020.88 ± 0.020.82 ± 0.030.88 ± 0.02 *35.29
1000.87 ± 0.030.80 ± 0.020.76 ± 0.010.81 ± 0.02 *40.44
SPAQ500.97 ± 0.020.92 ± 0.020.87 ± 0.030.92 ± 0.05 *32.35
1000.88 ± 0.030.84 ± 0.020.79 ± 0.010.83 ± 0.02 *38.97
Carrag.: Carrageenan, SP: S. petiolata: methanol, NH: n-Hexane, DCM: dichloromethane, AQ: aqueous diclofenac sodium = positive control, n: 3 with p ≤ 0.05 *, data were taken as mean ± SEM.
Table 5. Analgesic potential of the S. petiolata extracts.
Table 5. Analgesic potential of the S. petiolata extracts.
Treatments Dose Conc.Writhes No. Mean ± SEM% Reduction in Writhings
AA1.5 ml28.3 ± 0.03
Aspirin1 ml10.7 ± 0.0262.19
SPM50 (mg/kg)19.5 ± 0.07 **31.09
10013.9 ± 0.04 **50.88
SPDCM5020.5 ± 0.02 **27.56
10015.1 ± 0.04 **46.64
SPNH5021.6 ± 0.02 **23.67
10016.4 ± 0.03 **42.04
SPAQ5022.2 ± 0.04 **21.55
10017.3 ± 0.05 **38.86
AA: Acetic acid, SP: S. petiolata, M: methanol, NH = n-hexane, DCM: dicholoromethane, AQ: aqueous, aspirin= positive control, n” 3 with p ≤ 0.01 **, data were taken as mean ± SEM.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Mubin, S.; Rehman, N.U.; Murad, W.; Shah, M.; Al-Harrasi, A.; Afza, R. Scutellaria petiolata Hemsl. ex Lace & Prain (Lamiaceae).: A New Insight in Biomedical Therapies. Antioxidants 2022, 11, 1446. https://doi.org/10.3390/antiox11081446

AMA Style

Mubin S, Rehman NU, Murad W, Shah M, Al-Harrasi A, Afza R. Scutellaria petiolata Hemsl. ex Lace & Prain (Lamiaceae).: A New Insight in Biomedical Therapies. Antioxidants. 2022; 11(8):1446. https://doi.org/10.3390/antiox11081446

Chicago/Turabian Style

Mubin, Sidra, Najeeb Ur Rehman, Waheed Murad, Muddaser Shah, Ahmed Al-Harrasi, and Rabia Afza. 2022. "Scutellaria petiolata Hemsl. ex Lace & Prain (Lamiaceae).: A New Insight in Biomedical Therapies" Antioxidants 11, no. 8: 1446. https://doi.org/10.3390/antiox11081446

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop